(NP (NP Reversal/NN) (PP of/IN (NP apoptosis/NN)) (PP by/IN (NP the/DT leukaemia-associated/JJ E2A-HLF/NN chimaeric/JJ transcription/NN factor/NN)) ./.)
(S (S-COOD (S (NP-SBJ (NP (NP The/DT E2A-HLF/NN -LRB-/-LRB- (PP for/IN (NP hepatic/JJ leukaemia/NN factor/NN)) -RRB-/-RRB-) fusion/NN gene/NN) ,/, (VP formed/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP action/NN) (PP of/IN (NP the/DT t-LRB-17;19-RRB-/NN -LRB-q22;p13-RRB-/NN chromosomal/JJ translocation/NN))))) ,/,) (VP drives/VBZ (NP (NP the/DT leukaemic/JJ transformation/NN) (PP of/IN (NP early/JJ B-cell/NN precursors/NNS))))) ,/, but/CC (S (NP-SBJ (NP the/DT mechanism/NN) (PP of/IN (NP this/DT activity/NN))) (VP remains/VBZ (ADJP-PRD unknown/JJ)))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP report/VBP (SBAR that/IN (S (NP-SBJ-37 (NP human/JJ leukaemia/NN cells/NNS) (VP carrying/VBG (NP the/DT translocation/NN t-LRB-17;19-RRB-/NN))) (ADVP-TMP rapidly/RB) (VP died/VBD (PP by/IN (NP apoptosis/NN)) (SBAR-TMP (WHADVP-38 when/WRB) (S (NP-SBJ-39 *-37/-NONE-) (VP programmed/VBN (S (NP-SBJ *-39/-NONE-) (VP to/TO (VP express/VB (NP (NP a/DT dominant-negative/JJ suppressor/NN) (PP of/IN (NP the/DT fusion/NN protein/NN E2A-HLF/NN)))))) (ADVP *T*-38/-NONE-)))) ,/, (S (NP-SBJ */-NONE-) (VP indicating/VBG (SBAR that/IN (S (NP-SBJ the/DT chimaeric/JJ oncoprotein/NN) (ADVP probably/RB) (VP affects/VBZ (NP-COOD (NP cell/NN survival/NN) (CONJP rather/RB than/IN) (NP cell/NN growth/NN))))))))))) ./.)
(S (ADVP Moreover/RB) ,/, (SBAR-TMP (WHADVP-42 when/WRB) (S (NP-SBJ-41 *-40/-NONE-) (VP introduced/VBN (NP *-41/-NONE-) (PP into/IN (NP murine/JJ pro-B/JJ lymphocytes/NNS)) (ADVP *T*-42/-NONE-)))) ,/, (NP-SBJ-40 the/DT oncogenic/JJ E2A-HLF/NN fusion/NN protein/NN) (VP reversed/VBD (NP (ADJP-COOD both/CC (ADJP interleukin-3-dependent/JJ) and/CC (ADJP p53-mediated/JJ)) apoptosis/NN)) ./.)
(S (NP-SBJ (NP The/DT close/JJ homology/NN) (PP of/IN (NP (NP the/DT (NP (NP basic/JJ region\/leucine/NN zipper/NN) (PRN -LRB-/-LRB- (NP bZIP/NN) -RRB-/-RRB-)) (UCP-COOD (ADJP DNA-binding/JJ) and/CC (NP dimerization/NN)) domain/NN) (PP of/IN (NP HLF/NN)))) (PP to/TO (NP (NP that/DT) (PP of/IN (NP (NP the/DT CES-2/NN cell-death/NN specification/NN protein/NN) (PP of/IN (NP Caenorhabditis/NN elegans/NNS))))))) (VP suggests/VBZ (NP (NP a/DT model/NN) (PP of/IN (NP leukaemogenesis/NN)) (SBAR (WHPP-43 in/IN (WHNP which/WDT)) (S (NP-SBJ E2A-HLF/NN) (VP blocks/VBZ (NP (NP an/DT early/JJ step/NN) (PP within/IN (NP an/DT (ADJP evolutionarily/RB conserved/VBN) cell-death/NN pathway/NN))) (PP *T*-43/-NONE-)))))) ./.)
